Development of a complementing cell line and a system for construction of adenovirus vectors with E1 and E2a deleted - PubMed (original) (raw)

Development of a complementing cell line and a system for construction of adenovirus vectors with E1 and E2a deleted

H Zhou et al. J Virol. 1996 Oct.

Abstract

Although adenovirus vectors offer many advantages, it would be desirable to develop vectors with improved expression and decreased toxicity. Toward this objective, an adenovirus vector system with deletion of both the El and E2a regions was developed. A 5.9-kb fragment of the adenovirus type 5 (Ad5) genome containing the E2a gene and its early and late promoters was transfected into 293 cells. A complementing cell line, designated 293-C2, expressed the E2a mRNA and protein and was found to complement the defect in Ad5 viruses with temperature-sensitive or deletion mutations in E2a. A deletion of 1.3 kb removing codons 40 to 471 of the 529 amino acids of E2a was introduced into plasmids for preparation of viruses and vectors. An Ad5 virus with disruption of the El gene and deletion of E2a grew on 293-C2 cells but not on 293 cells. Vectors with E1 and E2a deleted expressing Escherichia coli beta-galactosidase or human alpha1-antitrypsin were prepared and expressed the reporter genes after intravenous injection into mice. This vector system retains sequences in common between the complementing cell line and the vectors, including 3.4 kb upstream and 1.1 kb downstream of the deletion. These vectors have potential advantages of increased capacity for insertion of transgene sequences, elimination of expression of E2a, and possibly reduction in expression of other viral proteins. Although the titers of the vectors with deleted are about 10- to 30-fold below those of vectors with E2a wild-type regions, the former vectors are suitable for detailed studies with animals to evaluate the effects on host immune responses, on duration of expression, and on safety.

PubMed Disclaimer

Similar articles

• A Cre-expressing cell line and an E1/E2a double-deleted virus for preparation of helper-dependent adenovirus vector.
  Zhou H, Zhao T, Pastore L, Nageh M, Zheng W, Rao XM, Beaudet AL. Zhou H, et al. Mol Ther. 2001 Apr;3(4):613-22. doi: 10.1006/mthe.2001.0288. Mol Ther. 2001. PMID: 11319924
• Generation of an adenovirus vector lacking E1, e2a, E3, and all of E4 except open reading frame 3.
  Gorziglia MI, Lapcevich C, Roy S, Kang Q, Kadan M, Wu V, Pechan P, Kaleko M. Gorziglia MI, et al. J Virol. 1999 Jul;73(7):6048-55. doi: 10.1128/JVI.73.7.6048-6055.1999. J Virol. 1999. PMID: 10364357 Free PMC article.
• A new vector system with inducible E2a cell line for production of higher titer and safer adenoviral vectors.
  Zhou H, Beaudet AL. Zhou H, et al. Virology. 2000 Sep 30;275(2):348-57. doi: 10.1006/viro.2000.0515. Virology. 2000. PMID: 10998335
• Second-generation adenovirus vectors.
  Wang Q, Finer MH. Wang Q, et al. Nat Med. 1996 Jun;2(6):714-6. doi: 10.1038/nm0696-714. Nat Med. 1996. PMID: 8640568 Review. No abstract available.
• [Development of a novel adenovirus vector exhibiting microRNA-mediated suppression of the leaky expression of adenovirus genes].
  Shimizu K, Sakurai F, Tachibana M, Mizuguchi H. Shimizu K, et al. Yakugaku Zasshi. 2012;132(12):1407-12. doi: 10.1248/yakushi.12-00235-5. Yakugaku Zasshi. 2012. PMID: 23208048 Review. Japanese.

Cited by

• Role for the adenovirus IVa2 protein in packaging of viral DNA.
  Zhang W, Low JA, Christensen JB, Imperiale MJ. Zhang W, et al. J Virol. 2001 Nov;75(21):10446-54. doi: 10.1128/JVI.75.21.10446-10454.2001. J Virol. 2001. PMID: 11581412 Free PMC article.
• NF-κB promotes leaky expression of adenovirus genes in a replication-incompetent adenovirus vector.
  Machitani M, Sakurai F, Wakabayashi K, Nakatani K, Shimizu K, Tachibana M, Mizuguchi H. Machitani M, et al. Sci Rep. 2016 Jan 27;6:19922. doi: 10.1038/srep19922. Sci Rep. 2016. PMID: 26814140 Free PMC article.
• Effect of the E4 region on the persistence of transgene expression from adenovirus vectors.
  Armentano D, Zabner J, Sacks C, Sookdeo CC, Smith MP, St George JA, Wadsworth SC, Smith AE, Gregory RJ. Armentano D, et al. J Virol. 1997 Mar;71(3):2408-16. doi: 10.1128/JVI.71.3.2408-2416.1997. J Virol. 1997. PMID: 9032378 Free PMC article.
• Adenovirus with DNA Packaging Gene Mutations Increased Virus Release.
  Wechman SL, Rao XM, McMasters KM, Zhou HS. Wechman SL, et al. Viruses. 2016 Dec 20;8(12):333. doi: 10.3390/v8120333. Viruses. 2016. PMID: 27999391 Free PMC article.
• Persistence of recombinant adenovirus in vivo is not dependent on vector DNA replication.
  Nelson JE, Kay MA. Nelson JE, et al. J Virol. 1997 Nov;71(11):8902-7. doi: 10.1128/JVI.71.11.8902-8907.1997. J Virol. 1997. PMID: 9343256 Free PMC article.

References

1. 1. Virology. 1992 Oct;190(2):624-34 - PubMed
2. 1. Am Rev Respir Dis. 1963 Sep;88:SUPPL 394-403 - PubMed
3. 1. J Clin Invest. 1993 Sep;92(3):1580-6 - PubMed
4. 1. Proc Natl Acad Sci U S A. 1994 May 10;91(10):4407-11 - PubMed
5. 1. Hum Gene Ther. 1994 Feb;5(2):165-73 - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Atypon
  • Europe PubMed Central
  • PubMed Central

• Other Literature Sources

  • The Lens - Patent Citations Database

• Miscellaneous

  • NCI CPTAC Assay Portal